<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1817-7433</journal-id>
<journal-title><![CDATA[Revista Científica Ciencia Médica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cient Cienc Méd]]></abbrev-journal-title>
<issn>1817-7433</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Medicina, Universidad Mayor de San Simón.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1817-74332021000100008</article-id>
<article-id pub-id-type="doi">10.51581/rccm.v24i1.337</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[HEPATITIS B Y C EN PERSONAS CON VIH DEL INSTITUTO PARA EL DESARROLLO HUMANO]]></article-title>
<article-title xml:lang="en"><![CDATA[HEPATITIS B AND C IN PEOPLE WITH HIV FROM THE INSTITUTE FOR HUMAN DEVELOPMENT]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Garay Quiroga]]></surname>
<given-names><![CDATA[Jhemel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valdez Carrizo]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto para el Desarrollo Human Servicio de Salud ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Bolivia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto para el Desarrollo Humano  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Bolivia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2021</year>
</pub-date>
<volume>24</volume>
<numero>1</numero>
<fpage>8</fpage>
<lpage>12</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1817-74332021000100008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1817-74332021000100008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1817-74332021000100008&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: La coinfección del VIH con la hepatitis B o C es causa de patología hepática crónica, con diversas seroprevalencias en diferentes regiones del mundo.  Objetivo: Conocer la seroprevalencia de hepatitis B y C en personas con VIH que acuden a consulta en el Instituto para el Desarrollo Humano, Cochabamba-Bolivia, gestión 2017-2018.  Materiales y Métodos: Estudio descriptivo, prospectivo-transversal, cuantitativo, no experimental. Se analizaron los resultados serológicos de los marcadores: Antígeno de superficie del virus hepatitis B, anticuerpo anti-core del virus de hepatitis B, anticuerpo contra el virus hepatitis C; historial de vacuna para hepatitis B y esquema de tratamiento antirretroviral, de 195 personas con VIH en el Instituto para el Desarrollo Humano, se realizó análisis bivariado para la obtención de datos.  Resultados: La seroprevalencia obtenida para hepatitis B es de 7,7% y hepatitis C de 0,5%; la coinfección entre VIH y hepatitis B es de 80% con esquema antirretroviral tenofovir/lamivudina. El grupo poblacional homosexual tiene un riesgo de 5,5 veces más de tener la co-infección de VIH y hepatitis B con un valor de p de 0,006; con relación a la inmunización para hepatitis B solo el 9,2% de los pacientes cuentan con el esquema completo.  Conclusión: Es imperativo ofertar las pruebas para hepatitis B y C a todas las personas con VIH; haciendo énfasis en los grupos más vulnerables (homosexuales); es importante el abastecimiento de dosis para la inmunización completa contra la hepatitis B en todos los servicios de salud públicos del país.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: HIV co-infection with hepatitis B or C is the cause of chronic liver disease, with various seropre- valences in different regions of the world.  Objective: To know the seroprevalence of hepatitis B and C in people with HIV who come for consultation at the Institute for Human Development, Cochabamba-Bolivia, management 2017-2018.  Materials and methods: Descriptive, prospective-cross-sectional, quantitative, non-experimental study. The serological results of the markers were analyzed: Hepatitis B virus surface antigen, Hepatitis B virus anti-core antibody, Hepatitis C virus antibody; Hepatitis B vaccine history and antiretroviral treatment scheme of 195 people with HIV at the Institute for Human Development, bivariate analysis was performed to obtain data.  Results: The seroprevalence obtained for hepatitis B is 7.7% and hepatitis C 0.5%; coinfection between HIV and hepatitis B is 80% with the antiretroviral regimen tenofovir / lamivudine. The homosexual population group has a 5.5 times risk of having HIV and hepatitis B co-infection with a p value of 0.006; Regarding immunization for hepatitis B, only 9.2% of patients have the complete scheme.  Conclusion: It is imperative to offer hepatitis B and C testing to all people with HIV; emphasizing the most vulnerable groups (homosexuals); The provision of doses for complete immunization against hepatitis B in all public health services in the country is important.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[VIH]]></kwd>
<kwd lng="es"><![CDATA[Hepatitis B]]></kwd>
<kwd lng="es"><![CDATA[Hepatitis C]]></kwd>
<kwd lng="es"><![CDATA[Tenofovir]]></kwd>
<kwd lng="es"><![CDATA[Lami vudina]]></kwd>
<kwd lng="en"><![CDATA[HIV]]></kwd>
<kwd lng="en"><![CDATA[hepatitis B]]></kwd>
<kwd lng="en"><![CDATA[hepatitis C]]></kwd>
<kwd lng="en"><![CDATA[tenofovir]]></kwd>
<kwd lng="en"><![CDATA[lamivudina]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soares Sampaio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Arraes de Alencar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes Freire]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalencia de la co-infección con hepatitis B y C en pacientes HIV positivos y factores de riesgo asociados]]></source>
<year>2009</year>
<volume>17</volume>
<numero>63</numero>
<issue>63</issue>
<page-range>12-7</page-range><publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laufer]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Quarleri]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bouzas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Coinfecciones por VHB y VHC en pacientes VIH positivos en la "era HAART": nuevos desafíos]]></article-title>
<source><![CDATA[MEDICINA (Buenos Aires)]]></source>
<year>2007</year>
<volume>67</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>82-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hepatitis B]]></article-title>
<source><![CDATA[Medicina &amp; Laboratorio]]></source>
<year>2011</year>
<volume>17</volume>
<page-range>311-29</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>OPS</collab>
<source><![CDATA[La hepatitis B y C bajo la lupa. La respuesta de salud pública en la Región de las Américas]]></source>
<year>2016</year>
<publisher-name><![CDATA[Washington, D.C.]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez-Hita]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Problemas metodológicos en las investigaciones sobre VIH/SIDA en Bolivia]]></article-title>
<source><![CDATA[Ciência &amp; Saúde Coletiva]]></source>
<year>2013</year>
<volume>18</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1321-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Padrón]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Jam]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bouza]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Cabanes]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Coinfección VIH - hepatitis B y C en la provincia de Cienfuegos]]></article-title>
<source><![CDATA[Rev Cubana Med Trop]]></source>
<year>2008</year>
<volume>60</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>141-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[D'Angelo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ameli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Chacón]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Coinfección de hepatitis B y/o hepatitis C en pacientes infectados por virus de inmunodefificiencia humana (VIH)]]></article-title>
<source><![CDATA[Rev Soc Ven Microbiol]]></source>
<year>2012</year>
<volume>32</volume>
<page-range>153-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-Artacho]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Téllez-Molina]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Vergas-García]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Coinfección por VIH/VHB: estrategias terapéuticas y control serológico]]></article-title>
<source><![CDATA[Rev Clin Esp]]></source>
<year>2013</year>
<volume>213</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>285-90</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Insfrán]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Coinfección VIH con Hepatitis B (Hvb) y Hepatitis C (Hvc) en el Laboratorio de Referencia del Programa Nacional De Control de VIH/SIDA]]></article-title>
<source><![CDATA[Rev. Inst Med Trop]]></source>
<year>2012</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-26</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[Y-S]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[S-Y]]></given-names>
</name>
<name>
<surname><![CDATA[Sheng]]></surname>
<given-names><![CDATA[W-H]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[H-Y]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[K-Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chuang]]></surname>
<given-names><![CDATA[Y-C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection]]></article-title>
<source><![CDATA[PLoS ONE]]></source>
<year>2016</year>
<volume>11</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[García-Samaniego]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Prieto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Documento de consenso de la AEEH sobre el tratamiento de la infección por el virus de la hepatitis B (2012)]]></article-title>
<source><![CDATA[Gastroenterol Hepatol]]></source>
<year>2012</year>
<volume>35</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>512-28</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lozano]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ayerdi]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hepatitis C: nuevos diagnósticos y seroconversiones en una clínica de infecciones de transmisión sexual en Madrid]]></article-title>
<source><![CDATA[Rev Esp Quimioter]]></source>
<year>2019</year>
<volume>32</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>440-4</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Brandy]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de vacuna frente a hepatitis B adyuvada con AS04C en pacientes VIH]]></article-title>
<source><![CDATA[Rev Esp Quimioter]]></source>
<year>2018</year>
<volume>31</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>105-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
